Please login if a current member. If not a Green Line member, you can join below.
The post Target was Hit on BioCryst Pharma $BCRX at $11 for a 21.5 % Gain (Long Term Portfolio). appeared first on Above The Green Line.
We will be happy to hear your thoughts
